分类： health

In a landmark moment for global reproductive health collaboration, the 23rd International Conference on Preimplantation Genetics officially opened its doors in Shanghai on April 25, 2026. This gathering marks the first time the leading international event in the specialized field of reproductive genetics has been hosted on Chinese soil, breaking new ground for cross-border knowledge exchange in the region.

Over four days, the conference brings together more than 300 clinical practitioners and research scientists from 23 countries and regions across the globe. Attendees have gathered to explore cutting-edge advancements reshaping preimplantation genetic testing, or PGT, a life-changing technology that plays a critical role in advancing global reproductive health and curbing the global prevalence of birth defects. The event is co-hosted by the Preimplantation Genetic Diagnosis International Society (PGDIS) and Renji Hospital Affiliated with Shanghai Jiao Tong University School of Medicine, alongside other leading national healthcare institutions.

Specialists in the field note that traditional prenatal screening methods have long carried a significant limitation: they frequently fail to detect single-gene genetic disorders early in pregnancy. When these conditions are identified after conception, they often leave families facing devastating decisions, imposing heavy long-term emotional and financial burdens that extend to broader society. PGT, widely recognized as a core technological tool for preventing birth defects, addresses this gap by allowing clinicians to conduct a highly precise analysis of an embryo’s genetic material before implantation. This process enables care teams to select only healthy embryos that do not carry pathogenic genetic mutations, drastically reducing the risk of inherited genetic conditions being passed to newborns.

This year’s conference agenda features deep dives into some of the most pressing topics in the field, including the expanding clinical use of non-invasive PGT techniques, as well as the ethical frameworks and real-world implementation practices for PGT designed to assess polygenic disease risk. In a highlight of the program, Chinese leading researchers and clinicians shared the latest breakthroughs and outcomes from PGT clinical adoption across China, offering global peers valuable insight into the nation’s rapid progress in the sector.

Global industry leaders have praised the milestone hosting of the conference in Shanghai, noting that the event reflects the city’s rising international influence in reproductive genetics and its sustained commitment to nurturing international partnership and innovation in life-saving healthcare technology. For the global reproductive health community, the conference is expected to drive faster, more equitable advancement of PGT technology, improving outcomes for families seeking to build healthy families across the world.

A decade-long research project led by scientists at Sun Yat-sen University Cancer Center in Guangzhou has yielded an artificial intelligence-powered innovation that is set to reshape radiation therapy for cancer, particularly nasopharyngeal carcinoma, by drastically improving precision and cutting down on clinician workload.

Nasopharyngeal carcinoma, which forms in the upper throat behind the nose, is primarily treated with radiation therapy. The stakes of this treatment are extraordinarily high: an undersized radiation field leaves sections of the tumor untreated, raising the likelihood of cancer recurrence, while an overly broad field can inflict irreversible damage to critical nearby structures including the brainstem, temporal lobe, middle ear, and optic nerve. Such collateral damage often triggers life-altering complications ranging from chronic headaches and memory loss to permanent hearing and vision impairment, severely diminishing a patient’s post-treatment quality of life.

To avoid these outcomes, clinicians must complete a meticulous pre-treatment step called target volume delineation, where they manually identify and trace the boundaries of both the tumor and surrounding healthy organs on medical scans to define the exact radiation field. Before this new technology was introduced, this demanding task required clinicians to maintain intense focus for three to six hours per patient, according to Sun Ying, a professor at the cancer center.

The complexity of the process is further compounded by changes in patient anatomy over the course of treatment. A full course of radiotherapy typically spans six to seven weeks and requires more than 30 separate treatment sessions. During this period, tumors often shrink and patients may experience weight loss that shifts the exact position of the remaining cancer. This means initial scans taken at the start of treatment quickly become outdated, leaving clinicians to update delineations repeatedly to avoid misaligned radiation delivery.

To solve these longstanding challenges, the research team led by the center’s vice-president Ma Jun, an academician of the Chinese Academy of Sciences, and Sun spent more than 10 years developing their proprietary AI-powered “digital dissection” technique. The system is trained on large datasets that map how nasopharyngeal tumors grow and shift over the course of treatment, allowing it to automatically generate highly precise outline of target radiation areas in real time as a patient’s condition changes. Clinicians then only need to review and make minor adjustments to the AI-generated outline before finalizing an adaptive radiotherapy plan, which adjusts to current patient anatomy during each session.

In a recent demonstration at the center, the entire process — from integrated CT imaging to completed adaptive radiation delivery — was finished in under 30 minutes for a nasopharyngeal carcinoma patient.

Zhou Guanqun, a chief physician at the center, noted that the new system already outperforms 50% of specialist physicians in terms of delineation accuracy. Beyond accuracy gains, the technology has cut the variation in outline work between different clinicians by 50% and boosted workflow efficiency by more than five times, bringing total treatment time for each case down to roughly 30 minutes from the multiple hours previously required for manual delineation alone.

The innovation marks a significant step forward in making precision radiotherapy more accessible and consistent, addressing a critical gap in cancer care that has long depended on individual clinician skill and experience.

Every morning at 6:30 across Japan, a familiar piano melody drifts through radio airwaves, calling millions of people to begin their day with movement. This centuries-old tradition, known as Radio Taiso (translated as Exercise Radio), has become a woven thread in Japanese daily life, uniting people across generations in parks, office campuses, schoolyards, and living rooms.

What makes Radio Taiso enduringly popular is its remarkable accessibility. The 10-minute routine consists of simple calisthenic movements, from overhead stretches and torso twists to arm swings and gentle squats that can be adjusted to any fitness level. Participants can make the workout as low-impact or as strenuous as they prefer, with options to do every move standing or seated. Split into three 3-minute segments that gradually increase in difficulty, the sequence requires no specialized equipment, and beginners can pick up the choreography after just one or two sessions. Every movement is repeated four to eight times, with consistent cues to breathe slowly and stay relaxed, keeping the routine gentle even for older participants.

### A Tradition Steeped in History
Radio Taiso’s origins trace back 100 years, inspired by a similar radio exercise program launched by Metropolitan Life Insurance in the United States. In the 1920s, Japanese postal ministry officials brought the concept home after observing the program overseas, and Radio Taiso was formally introduced to the public in 1928, coinciding with the enthronement of Emperor Hirohito. Within 10 years, millions of Japanese people were joining the daily routine, with postal workers leading outreach by distributing instructional pamphlets and hosting local training sessions.

After Japan’s defeat in World War II, the group exercise program was banned during the U.S. occupation, with authorities viewing mass collective practice as carrying potential militaristic and totalitarian overtones. But popular demand for the ritual never faded, and group Radio Taiso sessions resumed in 1951, just one year before the formal end of the U.S. occupation. Today, the tradition is stronger than ever: a 2023 survey from the Japan Radio Taiso Federation found that more than 20 million Japanese people practice the routine at least once a week, out of the country’s total population of 122 million. It has also spread globally, with particularly large followings in countries like Brazil, which is home to the world’s largest population of Japanese descent outside Japan. Anyone curious can also find English-language and multilingual Radio Taiso tutorials on YouTube to try the routine at home.

### More Than Exercise: A Community Anchor for Aging Japan
Beyond physical benefits, Radio Taiso has long served as a critical social space, especially for Japan’s large elderly population. In Tokyo’s sprawling Kiba Park, a group of regulars gathers almost every morning to move together. Eighty-eight-year-old Mieko Kobayashi, a longtime participant, says the routine keeps her feeling well, while her 77-year-old friend Yoshiko Nagao notes that the gathering is a lifeline for many elderly residents who live alone. “We even come on New Year’s Day,” Nagao says, explaining that post-workout walks and casual conversation are just as important as the exercise itself.

Eighty-three-year-old Kenji Iguchi, who has practiced Radio Taiso regularly for 20 years and appears decades younger than his age, says the routine keeps his joints — particularly his knees and back — healthy. He wakes at 5 a.m. every day, walks through the park before the 6:30 session, and counts the social connection with familiar fellow participants as one of his favorite weekly rituals.

Japan consistently boasts one of the highest life expectancies in the world, with an average of 85 years — just slightly behind Hong Kong, and six years higher than the United States’ average of 79. Last year, the Japanese government confirmed that 99,763 people aged 100 or older are currently living in the country, marking the 55th consecutive year that the number of centenarians has hit a new national record. Japan holds the global record for the highest share of centenarians per capita, and experts often attribute the country’s longevity to a combination of healthy diet, universal high-quality healthcare, and cultural norms that encourage consistent physical activity across all ages — including the simple daily ritual of Radio Taiso.

In a landmark development for medical data collaboration and pharmaceutical innovation, Beijing Tongren Hospital, a leading Chinese medical institution specializing in ophthalmology, has announced the completion of the world’s first legally compliant transaction of a full-dimensional ophthalmic follow-up dataset, with agreements signed with two major drugmakers: China’s Hengrui Pharmaceuticals and German multinational Bayer.

Hospital president Yuan Jin detailed that the sold dataset is drawn from the facility’s comprehensive multi-dimensional, fully structured quantitative ophthalmic database, which has been constructed around anonymized health records from a 100,000-strong patient population. The dataset covers full-cycle clinical follow-up information for all common high-prevalence eye diseases, including keratopathy, dry eye syndrome, myopia, glaucoma, cataracts, and diabetic retinopathy.

Unlike fragmented medical data collections, this integrated dataset combines multiple layers of clinically valuable information: patient demographic characteristics, confirmed clinical diagnoses, adopted treatment plans, long-term post-treatment follow-up records, and standardized ophthalmic imaging results. This rich, multi-faceted real-world data is expected to fill critical gaps in ophthalmic drug development, supporting not only early-stage new drug research but also post-marketing efficacy evaluations, medical insurance access assessments, and the training of clinical artificial intelligence tools focused on eye health.

To address growing global concerns around medical data privacy and regulatory compliance, the transaction was conducted through two established, authoritative Chinese platforms: the National AI Application Pilot Base for the Medical Sector and the Beijing International Big Data Exchange. Prior to the transaction, all sensitive personal identifiable information was fully removed and anonymized, aligning with China’s strict personal health information protection regulations and eliminating privacy risks for former patients.

Beijing Tongren Hospital emphasized that the core goal of this pioneering transaction is to advance ophthalmic medical research and ultimately improve treatment outcomes for patients living with eye diseases around the world. This milestone is widely expected to set a regulatory and operational precedent for future compliant medical data transactions that balance innovation, public health benefit, and patient privacy protection.

Leading orthopedic and spine specialists from China and the United States have issued a critical public warning: a substantial share of patients currently recommended for orthopedic surgery do not actually need invasive intervention, and overreliance on imaging alone is driving unnecessary procedures that put patients at avoidable risk.

The consensus was reached during a high-level joint forum held in Beijing on Tuesday, organized by global medical consultancy Saint Lucia Consulting, Xinhua Health, and New York’s globally ranked Hospital for Special Surgery (HSS), a leading institution for musculoskeletal care.

Todd Albert, Surgeon-in-Chief Emeritus and the Richard Rogers Chair to Advance Spine Care at HSS, shared data illustrating the scale of the issue: roughly 35 percent of patients who travel to HSS to seek a second medical opinion after being told they need surgery ultimately end up receiving effective non-surgical treatment instead.
Zhang Jianguo, chair of orthopedics at Beijing’s Peking Union Medical College Hospital, echoed this finding, noting that many patients referred to his center after a surgery recommendation from other facilities ultimately do not require any invasive procedure at all. Zhang emphasized that surgical decisions cannot be made based on imaging scans alone. “You cannot decide on surgery based solely on imaging results,” he said. “You have to look at the patient’s symptoms, physical signs, and functional limitations.”

Forum participants also highlighted the growing value of cross-border medical collaboration in reducing unnecessary procedures. Albert stressed that international cooperation is not just about encouraging patients to seek treatment abroad. Instead, the core benefit lies in streamlined preoperative assessment, secure cross-border sharing of imaging data, and collaborative expert consultations that help patients make informed choices about whether to pursue care at home or overseas. This model, Albert added, cuts down on unnecessary international referrals and wasted, costly trips for patients who do not need offshore intervention.

When it comes to complex orthopedic cases — including severe spinal deformities, age-related degenerative conditions, revision surgeries, and patients managing multiple coexisting chronic health conditions — care requires a far more comprehensive approach than just surgical skill, Zhang explained. “Complex orthopedics is not just about surgical technique anymore,” he said. “It’s a systemic project. The more complex the patient, the more you need multiple disciplines including respiratory, anesthesia, neurology and rehabilitation working together before the surgery even happens.”

To address the gap in access to high-quality expert input for uncertain orthopedic cases, Saint Lucia Consulting launched a new international orthopedic care program at the conclusion of Tuesday’s forum. The initiative is tailored specifically for patients living with complex spinal and joint conditions, and offers a full suite of services including formal international case reviews, second opinions from top global specialists, coordination for cross-border treatment when needed, rehabilitation planning support, and long-term clinical follow-up.
Cheng Xiaoyu, deputy general manager and rotating medical director of Saint Lucia Consulting, noted that the program is designed to move quickly for patients facing confusing diagnoses, conflicting medical recommendations, or poor outcomes from prior treatment. The initiative can connect patients to leading global orthopedic specialists for a formal review within 72 hours. “What complex orthopedic patients often lack, is not treatment opportunities, but the ability to make high-quality decisions at critical moments,” Cheng said.

As India enters the peak of its pre-monsoon summer season, the country’s official meteorological department has issued an urgent heatwave warning for swathes of northern, central and western India, with the national capital Delhi bracing for severe extreme heat conditions over the coming weekend.

The alert follows a record-breaking hot day on Thursday, when thermometers in multiple parts of Delhi pushed past the 40-degree Celsius mark, marking one of the highest daily temperature readings recorded in the city so far this year. Forecasters added that abnormal above-average temperatures will persist across Madhya Pradesh and Rajasthan, two large states in central and western India, for at least the next 48 to 72 hours, with temperatures projected to climb an additional 2 to 3 degrees Celsius across northern and central regions by Friday.

Extreme summer heat is a life-threatening hazard across India, where prolonged exposure to scorching conditions triggers a range of heat-related illnesses that have claimed hundreds of lives in severe heatwave seasons in recent years. In response to the rising risk, Delhi’s education department moved earlier this week to implement protective guidelines for schools across the capital. The new rules require schools to suspend all outdoor open-air classes, limit or move large daily school assemblies indoors, and install regular hydration reminders, with bells scheduled to ring every 45 to 60 minutes to prompt students to drink water.

The looming heatwave also underscores the growing impact of human-caused climate change on India’s weather patterns, according to recent research. A 2024 analysis published in the leading medical journal *The Lancet* found that nearly one-third of all heatwave days recorded across India in 2024 were directly attributable to long-term global warming driven by climate change. The research also quantified the massive economic toll of rising heat: in 2024 alone, excessive heat exposure cost India an estimated 247 billion potential labor hours, most lost in the high-exposure agriculture and construction sectors, adding up to a total economic loss of roughly $194 billion (around £151 billion).

Public health experts warn that prolonged exposure to extreme heat overwhelms the human body’s natural temperature regulation system, creating severe health risks that can turn fatal for vulnerable groups. Common complications include dehydration, heatstroke, and heightened cardiovascular stress, with outdoor laborers, elderly residents, infants and young children facing the highest risk of severe outcomes. Beyond health impacts, extreme heat also exacerbates existing infrastructure gaps, with vulnerable communities in informal urban settlements facing heightened water shortages as demand for drinking water surges during heatwaves.

A major data security incident has hit UK Biobank, one of the world’s largest long-term public health research initiatives, after listings advertising access to records of 500,000 project participants were found for sale on Alibaba, the Chinese e-commerce giant, UK government officials have confirmed.

UK Technology Secretary Ian Murray confirmed details of the breach in a statement to Members of Parliament this week, noting that the charity that manages UK Biobank first notified the UK government of the unauthorized listings on Monday. In an effort to address widespread public concern, Murray emphasized that none of the data included in the advertised listings contained direct personal identifiable information, including full names, residential addresses, contact information, or telephone numbers.

Founded in 2006, UK Biobank holds anonymized genetic, lifestyle and health records from 500,000 volunteer participants across the United Kingdom. The dataset has become a foundational resource for global medical research, enabling groundbreaking advances in the detection and treatment of conditions ranging from dementia and multiple types of cancer to Parkinson’s disease, improving health outcomes for millions worldwide.

In a public statement released after the incident, UK Biobank Chief Executive Professor Sir Rory Collins acknowledged that the unauthorized listings, even temporary ones, would alarm project participants. “We want to reassure you that all the data are de-identified; they do not contain any personally identifying information (such as names, addresses, dates of birth, and NHS numbers),” Collins said. The institution added that it is conducting a full internal investigation into the incident, and extended gratitude to the UK and Chinese governments, as well as Alibaba, for their rapid cooperation in addressing the issue.

Murray confirmed that as of the latest update, no successful purchases of the data were recorded from the three unauthorized listings posted to the platform. The listings have already been removed from Alibaba’s site following coordinated action between all involved parties, he added.

The UK’s Information Commissioner’s Office (ICO), the national data protection regulator, has also launched its own enquiry into the incident. An ICO spokesperson noted that personal health information is categorized as extremely sensitive data, noting that the public rightfully expects strict secure handling of such records, and all organizations processing health data hold a legal responsibility to protect it. “UK Biobank has made us aware of an incident and we are making enquiries,” the spokesperson added.

Alibaba has not yet released an official statement or comment on the incident as of press time.

China’s National Healthcare Security Administration (NHSA) has launched a comprehensive framework of national pricing guidelines that aims to streamline access to innovative medical treatments and standardize essential care services for elderly and pediatric populations, marking a major step forward in balancing technological innovation, industry development and public affordability.

As of the latest update, the administration has rolled out 39 batches of these guidelines, covering approximately 180 categories of emerging medical technologies, products and care services. The new framework establishes unified national standards for service nomenclature, clinical definitions, and overarching pricing structures across all public healthcare institutions, while leaving authority for local governments to set final, context-specific fee levels aligned with regional economic conditions.

Speaking at a press conference held on Monday, Dong Zhaohui, deputy director of the NHSA’s price bidding and purchasing department, outlined that the guidelines encompass a wide range of groundbreaking novel therapies. These include high-tech interventions such as surgical robotics, remote surgical procedures, brain-computer interface (BCI) implants, artificial heart devices, cochlear implants, artificial larynx devices, and high-intensity focused ultrasound treatment. When China granted the world’s first commercial approval for a BCI implant in March this year, the corresponding pricing guideline was released immediately to support rapid clinical rollout.

Beyond neurological and device-based innovations, the framework also covers cutting-edge cancer treatments, including proton radiotherapy, heavy ion radiotherapy, and boron neutron capture therapy — interventions that have long been out of reach for many patients due to unclear pricing and limited infrastructure. Dong explained that when drafting the guidelines, regulators factored in multiple key priorities: fair returns for medical innovators, cost burdens for healthcare institutions, equitable patient access to new treatments, and practical implementation data from pilot regions such as Shanghai. The guidelines explicitly set reasonable payment caps per full treatment course, with a core goal of expanding affordable access for patients across the country.

To further accelerate the adoption of life-saving new technologies, Dong added that the NHSA is exploring a proactive pre-approval pricing model, which would release guidance during the clinical trial stage of novel therapies, rather than waiting for full commercial approval. This early clarity is expected to cut development timelines and help bring new treatments to patients faster.

Industry analysts and healthcare experts say the standardized pricing framework is already unlocking growth across China’s medical innovation ecosystem. Jiang Changsong, a professor at the National Institute of Healthcare Security at Capital Medical University, noted that under the new guidelines, government-referenced prices for invasive BCI implantation sit at around 7,000 yuan ($873) per procedure in Beijing, Hubei and Zhejiang, while non-invasive BCI implantation is priced at roughly 1,000 yuan.

“With a clear pricing benchmark in place, medical enterprises can accurately calculate the return cycle for their R&D investments, which makes investors far more willing to commit capital to innovation. Hospitals also gain a transparent, official basis for service charging, and as a result, the entire industry chain is put into smooth motion,” Jiang explained. He added that the guidelines have already had a tangible impact on advanced cancer radiotherapy infrastructure: with a clear price anchor in place, more regional governments are confident in planning and constructing new proton therapy centers, which will eventually eliminate the need for patients to travel long distances across the country and wait in lengthy queues for life-saving treatment.

For domestic medical device manufacturers, the standardized pricing framework is leveling the playing field in previously unregulated segments. Xing Yuzhu, executive deputy general manager of Beijing Surgerii Robotics Co, noted that before the new guidelines were introduced, surgical robot services lacked uniform national pricing standards, with fragmented pricing structures largely controlled by a small number of leading international companies. Under the new rules, fee structures for both primary surgical and auxiliary robotic procedures are clearly defined, with tiered pricing set based on the level of robotic involvement in each procedure. This structure enables domestic manufacturers to compete on a more equal footing with global brands while still ensuring they can earn reasonable returns on their innovation investments.

In addition to supporting cutting-edge medical innovation, the new pricing guidelines also address pressing public welfare priorities aligned with China’s policy goals. To support the development of a birth-friendly society, the NHSA has added standardized pricing for a range of childbirth-related services, including fetal color ultrasound examinations, labor pain relief, family companionship during delivery, neonatal inpatient beds, general newborn nursing, and specialized care for premature infants.

To improve access to high-quality, affordable care for China’s aging population, the administration has also introduced standardized pricing items for a full spectrum of elderly care services. These include 24/7 “companion-free” non-medical inpatient care, home care visits, end-of-life hospice care, home-based hospital beds, online follow-up consultations, and remote health monitoring, all designed to bring essential care services closer to elderly populations.

Dong noted that under the guidelines, one-to-several “companion-free” care services are priced between 100 and 180 yuan per day across different regions, far lower than the 300 to 500 yuan typically charged by independent private caregivers. “This framework not only eases the financial burden on families caring for elderly relatives, but also helps attract more skilled talent to the professional nursing industry,” Dong said.

As China prepares for the upcoming five-day May Day holiday starting May 1, the country’s top public health authority has issued a formal warning over growing infectious disease threats, calling for stepped-up public vigilance to curb outbreaks during a period expected to see surges in travel and large-scale public gatherings. In a press briefing held in Beijing on Wednesday, April 22, Xi Jingjing, spokesperson for the National Disease Control and Prevention Administration, announced that influenza and rhinovirus transmission across China has followed a steady upward trajectory since the beginning of April 2026.

With warmer spring temperatures shifting toward summer conditions, the authority is also urging heightened awareness of mosquito-borne and intestinal infectious diseases that typically become more active during this seasonal transition. Xi specifically highlighted four diseases as key priorities for precaution: dengue fever, chikungunya fever, norovirus infection, and hand, foot and mouth disease, all of which carry heightened transmission risk when crowds of travelers converge in shared spaces.

Noting that weather patterns during the shift from spring to summer can be highly unpredictable, with sudden shifts in temperature, Xi offered targeted guidance for the public to reduce their risk of illness. She recommended that travelers pack flexible clothing options to adapt to changing conditions, and that all people planning trips check the latest infectious disease activity updates at their destination before departing. Food and water hygiene, she emphasized, is a critical line of defense against intestinal pathogens spread through contaminated consumption.

For travelers and residents engaging in outdoor activities, Xi urged consistent measures to prevent bites from mosquitoes and ticks, which are increasingly active as temperatures rise. She also advised the public to avoid close contact with wild marmots when hiking or visiting natural areas, a precaution designed to reduce the risk of tick-borne or zoonotic disease transmission.

The National Disease Control and Prevention Administration closed its warning with additional public guidance: all residents, particularly caregivers for children and guardians of older adults, should monitor health closely for any signs of infectious disease in the weeks surrounding the holiday. Anyone who develops symptoms consistent with the highlighted diseases is encouraged to seek prompt medical evaluation to prevent further spread and ensure timely care.

Breast cancer patients globally may soon access a revolutionary new treatment option, developed by a surgical team based in southern China, that eliminates the need for secondary follow-up operations and leaves no visible scarring on the breast — addressing two of the most distressing drawbacks of conventional breast cancer care.

The innovative procedure was created by Liao Ning, lead of the breast surgery department at Guangdong Provincial People’s Hospital, and integrates three cutting-edge medical tools into one streamlined workflow: real-time ultrasound imaging, a fluorescent contrast dye that clearly demarcates tumor tissue from healthy breast cells, and a high-precision robotic surgical system. Peer-reviewed findings from the team’s clinical trials were recently published online in the *European Journal of Surgical Oncology*, marking international recognition of the technique’s safety and efficacy.

In standard breast-conserving surgery, between 10% and 15% of patients require a second procedure to remove residual cancerous tissue that is not detected or excised during the initial operation. Early clinical results for the new Chinese method show a 98.4% rate of complete tumor removal with clear, cancer-free margins, and no patients in the trial cohort required a follow-up surgery to address leftover malignant tissue.

The procedure demands close coordination among the surgical team: after the fluorescent dye is injected directly into the tumor under ultrasound guidance, the team has just five minutes to excise the highlighted tissue before the dye loses its visibility. The robotic system’s high-definition camera translates the invisible tumor boundary into a clear green visualization on the operating screen, while the device’s articulated mechanical arms perform excisions with precision between one and two millimeters — an accuracy that far outperforms manual surgical techniques.

Artificial intelligence also contributes to the procedure’s success before the first incision is made. AI algorithms process pre-operative scans and patient clinical data to construct a detailed 3D model of the tumor, map exact safe cutting margins, and generate a prediction of the breast’s final appearance after resection. This allows surgeons to plan both tumor removal and breast reshaping well in advance, reducing the risk of intra-operative error and suboptimal cosmetic outcomes.

Unlike conventional procedures that require incisions on the breast surface, all tumor removal work for the new method is done through a single small incision hidden in the armpit, leaving the outer breast completely free of visible scarring. For patients who previously faced an agonizing trade-off between cancer survival and preserving their body image and personal dignity, this breakthrough addresses both physical and psychological harms associated with traditional breast cancer treatment.